Small Interfering RNA Market Players:
- GE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Scientific
- Arbutus Biopharma
- Sanofi Genzyme
- Sylentis
- Arrowhead Research
- Genecon Biotechnologies
- Silent Therapeutics
- Horizon Discovery
- OPKO Health
- Agios Pharmaceuticals, Inc.
- Novartis
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of small interfering RNA is evaluated at USD 20.62 billion.
The global small interfering RNA market size was worth over USD 18.33 billion in 2025 and is poised to witness a CAGR of more than 13.9%, crossing USD 67.36 billion revenue by 2035.
The North America small interfering RNA (SiRNA) market is anticipated to capture a 37% share by 2035, driven by increasing healthcare spending and academic R&D initiatives.
Key players in the market include GE, Thermo Scientific, Arbutus Biopharma, Sanofi Genzyme, Sylentis, Arrowhead Research, Genecon Biotechnologies, Silent Therapeutics, Horizon Discovery, OPKO Health, Agios Pharmaceuticals, Inc., Novartis.
